Life Sciences

Fueled by an increase in stock-based compensation related to the company's spin-off from Harvard Bioscience last November, Holliston-based Harvard Apparatus Regenerative Technology, Inc. (HART) reported a net loss for the quarter of $3 million, or 39 cents per share; an increase from $2 million from for the same period in 2013.

Biotech firm Arrhythmia Research Technology of Fitchburg reported its first quarterly profit in three years, aided by a nearly 7-percent jump in revenue.

Marlborough-based RXi Pharmaceuticals Corp. , announced Friday what it called successful results of initial testing of its...

In a move it believes will improve its position in the Japanese drug-eluting stent market, Natick-based Boston Scientific Corp. (BSX) announced Thursday the launch of Promus Premier Stent System in the Asian country.

Fueled by sales of it its Ventricular Assist Systems, Framingham-based HeartWare International on Thursday announced a 35-percent jump in revenue for the first quarter, from $49.2 million in the first quarter of 2013 to $66.5 million.

Harvard Bioscience said winter weather dragged down first-quarter revenue slightly, as the life sciences manufacturer brought in $25.9 million, down 0.7 percent from $26.1 million in the first quarter of 2013.

Psychemedics Corp. of Acton reported a 9.5-percent gain in revenue for the first quarter, as the maker of highly sensitive drug tests prepares to move into the Brazilian market later this year.

Boston Scientific, lifted by growth in cardiac-treatment devices, reported a 4-percent jump in operational revenue for the first quarter along with net profits of $133 million, rebounding from a $454 million loss in the first quarter of 2013.

Framingham-based HeartWare International reissued a warning Thursday regarding serious issues with its Ventricular Assist System, which aids people with advanced stage heart failure. The company said it has received eight complaints of failed locking mechanisms in the patient driveline connection, which connect the device to an external controller used to power and monitor the device.

On the surface, Marlborough biotechnology company Advanced Cell Technology appears to be on a rocky road, with...